Metals One (AIM: MET1), a critical and precious metals early-stage project developer and investor, is pleased to announce its Ordinary shares have been approved...
E-Power Resources Inc. (CSE: EPR) (‘E-Power’ or the ‘Company’) is pleased to provide the results of recently completed metallurgical testwork from the Company’s flagship...
(TheNewswire) GRANDE PRAIRIE, ALBERTA TheNewswire – (Nov. 20, 2025): Angkor Resources Corp. (TSXV: ANK,OTC:ANKOF) (‘ANGKOR’ OR ‘THE COMPANY’) announces further analysis, assays, and conclusions...
(TheNewswire) Toronto, Ontario November 20, 2025 TheNewswire – Noble Mineral Exploration Inc. ( ‘Noble’ or the ‘Company’ ) (TSX-V:NOB, FRANKFURT: NB7, OTCQB:NLPXF) is pleased...
Bitcoin adoption is gaining traction as several US states propose measures to establish strategic reserves. The trend stems from broader discussions spearheaded recently by...
Pharmaceutical giant Johnson & Johnson (J&J) (NYSE:JNJ) has announced plans to acquire Intra-Cellular Therapies (NASDAQ:ITCI) in a US$14.6 billion deal, marking the largest acquisition...
Boab Metals (ASX:BML) is a base and precious metals explorer and developer progressing toward a final investment decision (FID) on its Sorby Hills project,...
The 2024 manganese market was impacted by several factors including growing demand for battery applications, geopolitical risks, production disruptions and strategic investments. Positive demand...
International Graphite (IG6:AU) has announced $4m Grant Awarded for Springdale & Collie advancement Download the PDF here. This post appeared first on investingnews.com
Ernest Mast, President and Managing Director, Cygnus Metals Ltd. (TSXV: CYG) (‘Cygnus Metals’ or the ‘Company’), and his team, joined Robert Peterman, Chief Commercial...
Basin Energy (BSN:AU) has announced Scandinavian Exploration and Uranium Policy Update Download the PDF here. This post appeared first on investingnews.com
The pharmaceutical industry is poised for a dynamic year in 2025. A confluence of positive trends suggests a brighter outlook ahead after declining earnings...
Today’s pharmaceutical market is facing the challenges of inflation, government-imposed drug price caps and waning demand for COVID-19 vaccines. However, the industry’s major underlying...